Trulieve Cannabis Corp.
TRLV
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.74B
Close$
$10.47
4.6% upside
Current Fair Value
4.6% upsideUndervalued by 4.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.74 Billion |
|---|---|
| Enterprise Value | $2.68 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.61 |
| Beta | 1.81 |
| Outstanding Shares | 192,714,241 |
Return
| Return on Equity | -61.80% |
|---|---|
| Return on Assets | -22.78% |
| Return on Invested Capital | -14.89% |
Valuation & Multiples
| P/E Ratio | -26.47 |
|---|---|
| PEG | -0.93 |
| Price to Sales | 2.0 |
| Price to Book Ratio | 3.34 |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | -9.09 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$268.54 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$221.86 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Trulieve Cannabis Corp.
5,000 employees
CEO: Kimberly A. Rivers Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as...